Janssen-Cilag
Records under this name other than patents Janssen-Cilag holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,834,025 | Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,119,650 | Aminophenyl derivatives as novel inhibitors of histone deacetylase Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,101,616 | Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,947,830 | Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,834,011 | Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,790,894 | Mycobacterial inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,044,073 | Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,193,205 | Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,767,679 | Sulfonylamino-Derivatives as Novel Inhibitors of Histone Deacetylase Formerly held In force · High confidence | In force | High confidence | |
| US 7,884,215 | 2-substituted benzimidazoles Formerly held In force · From the USPTO record | In force | From the USPTO record |